Amedica wins Down Under nod for Valeo interbody fusion line
Amedica (NSDQ:AMDA) said today it won regulatory clearance in Australia for its Valeo product line of interbody fusion devices. The Salt Lake City, Utah.-based company’s Valeo products are made from...
View ArticleNovel ultrasound device dev Sonavex raises $3m
John Hopkins spin-out Sonavex said today it raised $3 million in financing, including a $2.2 million closed Series A round to support its novel ultrasound technology. The round was led by Grey Sky...
View ArticleSunshine Heart closes $9m offering
Sunshine Heart (NSDQ:SSH) said today it closed an underwritten public offering, bringing in approximately $9.2 million in gross proceeds. The round included the full exercise of the underwriter’s...
View ArticleImproving the safety of imported foods through partnerships
Susan Mayne, Ph.D., Director of FDA’s Center for Food Safety and Applied Nutrition By: Susan Mayne, Ph.D., Camille Brewer, M.S., R.D., and Donald Prater, D.V.M. At FDA, we recognize that the...
View ArticleMedtronic touts drug-coated balloon in peripheral artery disease patients
Medtronic (NYSE:MDT) touted data today for its In.Pact Admiral drug-coated balloon in 2 sub-analyses of peripheral artery disease patients in the company’s In.Pact Global Study. The data were presented...
View ArticleEli Lilly’s diabetes drugs boost Q1 revenue, earnings
Shares in Eli Lilly (NYSE:LLY) fell slightly today as the company met expectations on Wall Street with its 1st quarter financial results. The company has faced its share of issues in the last year –...
View ArticleResMed launches AirMini CPAP, touts as world’s smallest
ResMed (NYSE:RMD) today launched its AirMini continuous positive airway pressure device, touting it as the world’s smallest machine of its kind. The newly launched AirMini weighs 0.66 lbs and is small...
View ArticleFresenius acquires generics drugmaker Akorn, Merck’s biosimilars biz
German healthcare company Fresenius (ETR:FRE) said today that it bought U.S. generic drugmaker Akorn Inc. (NSDQ:AKRX) for $4.75 billion and Merck KGaA’s biosimilars business. Since chief executive...
View ArticleAllergan wins FDA nod for TrueTear tear-inducing neurostim
Allergan (NYSE: AGN) said today it won FDA clearance for its TrueTear intranasal tear neurostimulator designed to stimulate tear production, touting it as the 1st of its kind. The TrueTear device is...
View Article3M posts Street-beating Q1 results, updates full-year guidance
Shares in 3M (NYSE:MMM) rose today after the company met expectations on Wall Street with its 1st quarter results. The St. Paul, Minn.-based company posted profits of $1.32 billion, or $2.16 per share,...
View ArticleALung submits FDA IDE app for HemoLung device
ALung Technologies said today it submitted an investigational device exemption application to the FDA as it seeks to begin a clinical study of its Hemolung Respiratory Assist System. The Pittsburgh,...
View ArticleHow medtech companies can benefit from agile marketing
[Image from unsplash.com]Getting a medical device to market can be tough. It has to go through several hoops at the FDA, including the 5-step premarket requirements that include: classifying the...
View ArticleTela Bio launches post-clinical OviTex ventral hernia repair study
Tela Bio said today it initiated a post-market clinical study of its OviTex reinforced bioscaffold designed for soft tissue repair, enrolling the 1st patient at La Jolla, Calif.’s Scripps Clinic. The...
View ArticleReva plans $40m convertible note offering
Reva Medical (ASX:RVA) said yesterday that it’s planning a $40 million convertible note offering with several institutional and 1 undisclosed corporate investor to fund the company’s ongoing needs,...
View ArticleIvantis launches 2nd IDE study of Hydrus microstent
Ivantis said today it won approval from the FDA to initiate a 2nd investigational device exemption trial of its Hydrus microstent, testing the device in patients with advanced glaucoma who are...
View ArticleNovartis misses on rev, tops sales estimates in Q1
Shares in Novartis (NYSE:NVS) rose today after the pharmaceutical company met expectations on Wall Street with its 1st quarter earnings, but missed on sales largely thanks to growing pressure from...
View ArticleGE Healthcare, Lantheus ink PET imaging agent development deal
GE Healthcare (NYSE:GE) and Lantheus Holdings(NSDQ:LNTH) said today they inked a definitive license agreement to continue the Phase III development and commercialization of the investigational...
View ArticleMassDevice.com +5 | The top 5 medtech stories for April 25, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleSpirox touts 1-year 1st-in-human study results of Latera nasal implant
Spirox today released 1-year data from the 1st-in-human study of its Latera absorbable nasal implant designed to support nasal cartilage and prevent nasal valve collapse, which can contribute to nasal...
View ArticleReport: Pharma relies on price hikes for growth
Despite growing pressure from lawmakers over the pharmaceutical industry’s pricey products, new research shows that pharma relied largely on price hikes for growth in 2016. A 120-page report from...
View Article